CD274 and neoplasm: Randomization was stratified by PD-L1 tumor status (combined positive score [CPS ≥ 1] vs. negative [CPS < 1]) and history of prior neoadjuvant or adjuvant treatment vs. de novo metastatic disease at initial diagnosis.